CAPLIPOINT logo

Caplin Point LAB LTD.

CAPLIPOINT·NSE·
2,715.70 +198.30 (+7.88%)
Market Cap20631.52 Cr
PE Ratio32.19
Volume19,57,453
Day High - Low2750.00 - 2511.00
52W High-Low2750.00 - 1500.30
DocStoX Score
6.9/10
Fair
Fair Value
Sign in to see
ROE
20.60%
Strong
P/E
32.19x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 500NIFTY SMALLCAP 250
Day2511
2750
52W1500
2750
DocStoX take

Supported by growth (8.8) and risk (8.7), but held back by valuation (1.9). Growth looks strong at 8.8, but that is offset by valuation at 1.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.9
/10
Fair
Quality
Excellent
ROE 20.6%
Valuation
Expensive
P/E 32.2×
Growth
Strong
Revenue +15.6% 5Y CAGR
Risk
Low risk
D/E 0.00
Momentum
Strong
97% of 52-week range

At a glance

Market Cap
₹20,632 Cr
52W High / Low
₹2750 / ₹1500
Dividend Yield
0.31%
Promoter Holding
70.57%
EPS (TTM)
₹84.36
Book Value
₹472.00

Key highlights

  • Low leverage — D/E 0.00
  • Healthy net margin (30%)
  • Profitable in all of the last 5 years
  • Valuation is weak (1.9/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

CAPLIN POINT LAB LTD. peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.